ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet.

$8.59  -0.08 (-0.92%)
As of 01/26/2022 15:59:56 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  38,283,841
Average volume:  1,000,426
Market cap:   $339,194,831
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B97LZ58
Valuation   (See tab for details)
PE ratio:   -13.52
PB ratio:   1.94
PS ratio:   125.49
Return on equity:   11.99%
Net income %:   756.97%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy